Plasma carnitine is associated with fatigue in chronic hepatitis C but not in the irritable bowel syndrome

Alimentary Pharmacology and Therapeutics

Volumn 33, Issue 8, 2011, Pages 961-968

  Anty, R ^a,b,c   Marjoux, S ^a,b,c   Bekri, S ^d,e,f   Degalleani, L ^b   Dainese, R ^a,b,c   Gelsi, E ^b   Cherikh, F ^b   Tran, A ^a,b,c   Piche, T ^a,b,c,g  

^a INSERM   (France)

^b UNIVERSITY HOSPITAL OF NICE   (France)

^c UNIVERSITÉ CÔTE D'AZUR   (France)

^d ROUEN UNIVERSITY HOSPITAL   (France)

^e Institut Hospitalo Universitaire de Recherche Biomédicale IHURB   (France)

^f UNIVERSITÉ DE ROUEN   (France)

^g CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CARNITINE; LEPTIN;

ADULT; ARTICLE; BLOOD LEVEL; BODY COMPOSITION; CARNITINE BLOOD LEVEL; CARNITINE DEFICIENCY; CONTROLLED STUDY; DISEASE SEVERITY; FATIGUE; FATIGUE IMPACT SCALE; FEMALE; HEPATITIS C; HUMAN; IRRITABLE COLON; LEPTIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; RATING SCALE;

ADULT; AGED; AGED, 80 AND OVER; BODY COMPOSITION; CARNITINE; CASE-CONTROL STUDIES; ELECTRIC IMPEDANCE; FATIGUE; FEMALE; HEPATITIS C, CHRONIC; HUMANS; IRRITABLE BOWEL SYNDROME; LEPTIN; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 79952783010     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2011.04608.x     Document Type: Article

References (28)

1. Kroenke MD, Wood DR, Mangelsdorff AD, Meier NJ, Powell JB,. Chronic fatigue in primary care. Prevalence, patient characteristics, and outcome. JAMA 1988; 260: 929-34.
2. Piche T, Gelsi E, Schneider SM, et al. Fatigue is associated with high circulating leptin levels in chronic hepatitis C. Gut 2002; 51: 434-9.
3. Huet PM, Deslauriers J, Tran A, Faucher C, Charbonneau J,. Impact of fatigue on the quality of life of patients with primary biliary cirrhosis. Am J Gastroenterol 2000; 95: 760-7. (Pubitemid 30123916)
4. Piche T, Huet PM, Gelsi E, et al. Fatigue in irritable bowel syndrome: characterization and putative role of leptin. Eur J Gastroenterol Hepatol 2007; 19: 237-43.
5. Swain MG,. Fatigue in chronic disease. Clin Sci (Lond) 2000; 99: 1-8. (Pubitemid 30479387)
6. Swain MG, Maric M,. Defective corticotropin-releasing hormone mediated neuroendocrine and behavioral reponses in cholestatic rats: implications for cholestatic liver disease-related sickness behaviors. Hepatology 1995; 22: 1560-4.
7. Li B, Lloyd ML, Gudjonsson H, Shug AL, Olsen WA,. The effect of enteral carnitine administration in humans. Am J Clin Nutr 1992; 55: 838-45.
8. Jogl G, Hsiao YS, Tong L,. Structure and function of carnitine acyltransferases. Ann N Y Acad Sci 2004; 1033: 17-29. (Pubitemid 39656735)
9. Swart I, Rossouw J, Loots JM, Kruger MC,. The effect of L-carnitine supplementation on plasma carnitine levels and various performance parameters of male marathon athletes. Nutr Res Rev 1997; 17: 405-14. (Pubitemid 27085988)
10. Plioplys AV, Plioplys S,. Serum levels of carnitine in chronic fatigue syndrome: clinical correlates. Neuropsychobiology 1995; 32: 132-8.
11. Kuratsune H, Yamaguti K, Lindh G, et al. Low levels of serum acylcarnitine in chronic fatigue syndrome and chronic hepatitis type C, but not seen in other diseases. Int J Mol Med 1998; 2: 51-6.
12. Pistone G, Marino A, Leotta C, Dell'Arte S, Finocchiaro G, Malaguarnera M,. Levocarnitine administration in elderly subjects with rapid muscle fatigue: effect on body composition, lipid profile and fatigue. Drugs Aging 2003; 20: 761-7. (Pubitemid 36995252)
13. Graziano F, Bisonni R, Catalano V, et al. Potential role of levocarnitine supplementation for the treatment of chemotherapy-induced fatigue in non-anaemic cancer patients. Br J Cancer 2002; 86: 1854-7.
14. Tomassini V, Pozzilli C, Onesti E, et al. Comparison of the effects of acetyl L-carnitine and amantadine for the treatment of fatigue in multiple sclerosis: results of a pilot, randomised, double-blind, crossover trial. J Neurol Sci 2004; 218: 103-8. (Pubitemid 38169402)
15. Rossini M, Di Munno O, Valentini G, et al. Double-blind, multicenter trial comparing acetyl l-carnitine with placebo in the treatment of fibromyalgia patients. Clin Exp Rheumatol 2007; 25: 182-8. (Pubitemid 46851421)
16. Bellinghieri G, Savica V, Mallamace A, et al. Correlation between increased serum and tissue L-carnitine levels and improved muscle symptoms in hemodialyzed patients. Am J Clin Nutr 1983; 38: 523-31. (Pubitemid 13010197)
17. Ciacci C, Peluso G, Iannoni E, et al. L-Carnitine in the treatment of fatigue in adult celiac disease patients: a pilot study. Dig Liver Dis 2007; 39: 922-8. (Pubitemid 47354979)
18. Neri S, Pistone G, Saraceno B, Pennisi G, Luca S, Malaguarnera M,. L-carnitine decreases severity and type of fatigue induced by interferon-alpha in the treatment of patients with hepatitis C. Neuropsychobiology 2003; 47: 94-7. (Pubitemid 36469847)
19. Wolkowicz P, Grenett H, Belousova M, Urthaler F,. Activation of leptin expression by an inhibitor of carnitine palmitoyltransferase-1. Int J Obes Relat Metab Disord 2004; 28: 649-51. (Pubitemid 38491159)
20. Van Weyenberg S, Buyse J, Janssens GP,. Increased plasma leptin through l-carnitine supplementation is associated with an enhanced glucose tolerance in healthy ponies. J Anim Physiol Anim Nutr (Berl) 2009; 93: 203-8.
21. Piche T, Saint-Paul MC, Dainese R, et al. Mast cells and cellularity of the colonic mucosa correlated with fatigue and depression in irritable bowel syndrome. Gut 2008; 57: 468-73. (Pubitemid 351442529)
22. Boulier A, Fricker J, Thomasset AL, Apfelbaum M,. Fat-free mass estimation by the two-electrode impedance method. Am J Clin Nutr 1990; 52: 581-5.
23. Cullen W, Kearney Y, Bury G,. Prevalence of fatigue in general practice. Ir J Med Sci 2002; 171: 10-2.
24. Simren M, Abrahamsson H, Svedlund J, Bjornsson ES,. Quality of life in patients with irritable bowel syndrome seen in referral centers versus primary care: the impact of gender and predominant bowel pattern. Scand J Gastroenterol 2001; 36: 545-52. (Pubitemid 32328447)
25. Selimoglu MA, Yagci RV,. Plasma and liver carnitine levels of children with chronic hepatitis B. J Clin Gastroenterol 2004; 38: 130-3. (Pubitemid 38134151)
26. Nozaki S, Tanaka M, Mizuno K, et al. Mental and physical fatigue-related biochemical alterations. Nutrition 2009; 25: 51-7.
27. Cleare AJ,. The neuroendocrinology of chronic fatigue syndrome. Endocr Rev 2003; 24: 236-52. (Pubitemid 36515286)
28. Piche T, Vanbiervliet G, Cherikh F, et al. Effect of ondansetron, a 5-HT3 receptor antagonist, on fatigue in chronic hepatitis C: a randomised, double blind, placebo controlled study. Gut 2005; 54: 1169-73. (Pubitemid 41025915)